HomeNewsBusinessIndian aviation veers toward non-metros in December, 13 cities see traffic better than pre-COVID levels

Indian aviation veers toward non-metros in December, 13 cities see traffic better than pre-COVID levels

Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.

January 26, 2021 / 13:13 IST
Story continues below Advertisement
Darbhanga airport
Darbhanga airport

December has seen air passenger traffic touch a new high in at least 13 cities, with numbers higher than pre-COVID-19 levels.

All the 13 are tier- 2 and 3 cities, underlining the recent trend in Indian aviation, where passenger traffic has picked up better in smaller destinations than in the metros. The list includes Gorakhpur, Prayagraj, Ludhiana, Belgaum and Srinagar.

Story continues below Advertisement

This is an improvement from November when six cities saw a year-on-year improvement. This is based on data from the Airports Authority of India.

"Domestic airline operations in December 2020 continued the gradual streak of improvement and stood at 57 percent of pre-COVID levels (v/s ~49 percent in November 2020)," analysts Swarnendu Bhushan and Sarfraz Bhimani of Motilal Oswal had said in a recent report.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show